Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 7, 1997, Pages 2239-2243

  Lanzi, R ^a   Manzoni, M F ^a   Andreotti, A C ^a   Malighetti, M E ^a   Bianchi, E ^a   Piceni Sereni, L ^a   Caumo, A ^b   Luzi, L ^a   Pontiroli, A E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; FATTY ACID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; ISOPHANE INSULIN; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIPOLYSIS; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030795379     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.7.4071     Document Type: Article

References (46)

1. Blackard WG, Hull EW, Lopez A. 1971 Effect of lipids on growth hormone secretion in humans. J Clin Invest. 50:1439-1443.
2. Fineberg SE, Horland AA, Merimee TJ. 1972 Free fatty acid concentrations and growth hormone secretion in man. Metabolism. 21:491-498.
3. Quabbe HJ, Bratzke HJ, Siegers U, et al. 1972 Studies on the relationship between plasma free fatty acids and growth hormone secretion in man. J Clin Invest. 51:2388-2398.
4. Imaki T, Shibasaki T, Shizume K, et al. 1985 The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab. 60:290-293.
5. Imaki T, Shibasaki T, Masuda A, et al. 1986 The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology. 118:2390-2394.
6. Casanueva FF, Villanueva L, Dieguez C, et al. 1987 Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 65:634-642.
7. Pontiroli AE, Lanzi R, Monti LD, Pozza G. 1990 Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects. J Endocrinol Invest. 13:539-542.
8. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D. 1992 Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 13:387-414.
9. Rosenfeld RG, Ceda G, Wilson DM, Dollar LA, Hoffman AR. 1984 Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells. Endocrinology. 114:1571-1575.
10. Rosenfeld RG, Ceda G, Cutler CW, Dollar LA, Hoffman AR. 1985 Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells. Endocrinology. 117:2008-2016.
11. Ceda G, Hoffman AR, Silverberg GD, Wilson DM, Rosenfeld RG. 1985 Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin. J Clin Endocrinol Metab. 60:1204-1209.
12. Betteridge A, Wallis M. 1979 Involvement of prostaglandins in the inhibition of growth hormone production in cultured pituitary cells by insulin. J Endocrinol. 80:239-248.
13. Melmed S. 1984 Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest. 73:1425-1433.
14. Melmed S, Neilson L, Slanina S. 1985 Insulin suppresses rat growth hormone messenger ribonucleic acid levels in rat pituitary tumor cells. Diabetes. 34:409-412.
15. Yamashita S, Melmed S. 1986 Insulin regulation of rat growth hormone gene transcription. J Clin Invest. 78:1008-1014.
16. Yamashita S, Melmed S. 1986 Effects of insulin on rat anterior pituitary cells. Inhibition of growth hormone secretion and mRNA levels. Diabetes. 35:440-447.
17. Ho KY, Veldhuis JD, Johnson MI, et al. 1988 Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 81:968-975.
18. Press M, Caprio S, Tamborlane WM, et al. 1992 Pituitary response to growth hormone releasing hormone in IDDM. Abnormal responses to insulin and hyperglyeemia. Diabetes. 41:17-21.
19. Diamond MP, Hallarman L, Starick-Zich K, et al. 1991 Suppression of counterregulatory hormone response to hypoglycaemia by insulin per se. J Clin Endocrinol Metab. 72:1388-1390.
20. Coppak SW, Jensen MD, Miles JM. 1994 In vitro regulation of lipolysis in humans. J Lipid Res. 35:177-193.
21. Peino R, Cordido F, Peñalva A, Alvarez CV, Dieguez C, Casanueva FF. 1996 Acipimox-mediated plasma free fatty acids depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. J Clin Endocrinol Metab. 81:909-913.
22. Andreotti AC, Lanzi R, Manzoni MF, Caumo A, Moreschi A, Pontiroli AE. 1994 Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism. 43:1207-1213.
23. Pontiroli AE, Manzoni MF, Malighetti ME, Lanzi R. 1996 Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids. J Clin Endocrinol Metab. 81:3998-4001.
24. Fuccella L, Goldaniga G, Lovisolo P, et al. 1980 Inhibition of lipolysis by nicotinic acid and by acipimox. Clin Pharmacol Ther. 28:790-795.
25. Stirling C, McAleer M, Reckless JPD, et al. 1985 Effect of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin Sci. 68:83-88.
26. Pontiroli AE, Lanzi R, Monti LD, Pozza G. 1991 Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin. J Clin Endocrinol Metab. 72:492-495.
27. Golay A, Swislocki ALM, Chen YDI, Jaspan JB, Reaven GM. 1986 Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab. 63:481-484.
28. Groop LC, Bonadonna RC, Del Prato S, et al. 1989 Glucose and free fatty acids metabolism in non insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest. 84:205-213.
29. Luzi L, Battezzati A, Perseghin G, et al. 1994 Combined pancreas and kidney transplantation normalizes protein metabolism in IDD uremic patients. J Clin Invest. 93:1948-1958.
30. Fulcher GR, Walker M, Farrer M, Johnson AS, Alberti KGMM. 1993 Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism. 42:308-314.
31. Partridge WM. 1986 Receptor-mediated peptide transport through the bloodbrain barrier. Endocr Rev. 7:314-330.
32. Baskin DG, Porte Jr D, Guest K, Dorsa DM. 1983 Regional concentrations of insulin in the rat brain. Endocrinology. 112:898-903.
33. Baskin DG, Stein LJ, Ikeda H, et al. 1985 Genetically obese Zucker rats have abnormally low brain insulin content. Life Sci. 36:627-633.
34. Folli F, Bonfanti L, Renard E, Kahn CR, Merighi A. 1994 Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci. 14:6412-6422.
35. McCaleb ML, Myers RD, Singer G, Willis G. 1979 Hypothalamic norepinephrine in the rat during feeding and push-pull perfusion with glucose, 2-DG, or insulin. Am J Physiol 236:R312-R321.
36. McCaleb ML, Byers RD. 1982 2-deoxy-D-glucose and insulin modify release of norepinephrine from rat hypothalamus. Am J Physiol 242:R596-R603.
37. McQueen A, Armstrong S, Singer G, Myers RD. 1976 Noradrenergic feeding system in monkey hypothalamus is altered by localized perfusion of glucose, insulin, 2-DG, and eating. Pharmacol Biochem Behav. 5:491-494.
38. Sauter A, Goldstein M, Engel J, Ueta K. 1983 Effect of insulin on central catecholamines. Brain Res. 260:330-333.
39. 2-induced growth hormone release in normal short and normal children. J Clin Endocrinol Metab. 61:229-233.
40. Rettori V, Milenkovic L, Aguila MC, McCann S. 1990 Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology. 126:2296-2301.
41. Bia MJ, DeFronzo RA. 1981 Extrarenal potassium homeostasis Am J Physiol 240:F257-F268.
42. 2-form of enzyme. Am J Physiol 258:C812-C817.
43. +) ATPase. Two mechanisms of stimulation. J Biol Chem. 266:15824-15831.
44. Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA. 1987 Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. J Clin Invest. 80:1784-1793.
45. Luzi L, Perseghin G, Regalia E, et al. 1997 Metabolic effects of liver transplantation in cirrhotic patients. J Clin Invest. 99:692-700.
46. Alba-Roth J, Muller OA, Schopohl J, von Werder K. 1988 Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab. 67:1186-1189.